Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants
Clinical trial NCT06577337 · RECRUITING
Trial details
- NCT number
- NCT06577337
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-12
- Primary completion
- 2026-11-16
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.